Physician profile
Daniel Jethanamest
NPI 1992849095
$16,815.62
in general payments reported to CMS, 2019-2025
7 companies · $5,118 in 2025
The $5,118 reported for 2025 was more than what 86% of Otology & Neurotology providers received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2021: $844 · 2022: $539 · 2023: $649 · 2024: $9,336 · 2025: $5,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $2,481 · Travel and Lodging: $1,873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,750.00 |
| Food and Beverage | $2,481.20 |
| Travel and Lodging | $1,872.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $11,686.91 | 2019-2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Iotamotion, INC. | $3,042.90 | 2022-2025 | Iotasoft, Iotasoft Insertion System |
| Med-El Corporation | $1,776.43 | 2025 | Bci 602 Kit, Adhear Professional Kit, Mi1250 Synchrony 2 Flexsoft |
| Advanced Bionics, LLC | $149.97 | 2024 | Hires Ultra Ci Hifocus Ms Electrode |
| Acclarent, INC | $84.79 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $38.41 | 2019 | |
| Integra Lifesciences Corporation | $36.21 | 2025 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Jethanamest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.